
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Risk factor modification remains key to managing patients with HIV and diabetes.
In this interview, filmed during the American Diabetes Association 78th Annual Scientific Sessions, Priscilla Hsue, MD, from the University of California San Francisco School of Medicine, discusses treating patients with HIV and diabetes.
Transcript
Priscilla Hsue, MD: So I think individuals with HIV and diabetes, they're at increased risk for things like cardiovascular disease. So I think really aggressive recognition of this increased risk, as well as risk factor modification, whether its with lipid lowering therapy, blood pressure medication, cigarette smoking, glucose management. So, all those would be critical.






